Corrections to "Prevalence of persistent symptoms after treatment for lyme borreliosis: a prospective observational cohort study" [The Lancet Regional Health - Europe 6 (2021) 100142]

Lancet Reg Health Eur. 2023 Mar 15:27:100622. doi: 10.1016/j.lanepe.2023.100622. eCollection 2023 Apr.

¹ Department of Internal Medicine, Division of Infectious Diseases & Center for Experimental and Molecular Medicine, Amsterdam UMC, University of Amsterdam, P.O. Box 22660, 1100 DD, Amsterdam, Netherlands.
² Department of Internal Medicine and Radboudumc Center for Infectious Diseases (RCI), Radboud University Medical Center, P.O. Box 9101, 6500 HB, Nijmegen, Netherlands.
³ National Institute for Public Health and the Environment (RIVM), Center for Infectious Disease Control, P.O. Box 1, 3720 BA, Bilthoven, Netherlands.
⁴ Department of Medical Psychology, Amsterdam UMC, University of Amsterdam, Amsterdam Public Health Research Institute, P.O. Box 22660, 1100 DD, Amsterdam, Netherlands.
⁵ Lyme Center Apeldoorn, Gelre Hospital, P.O. Box 9014, 7300 DS, Apeldoorn, Netherlands.
⁶ National Institute for Public Health and the Environment (RIVM), Department for Statistics, Informatics and Modeling, P.O. Box 1, 3720 BA, Bilthoven, Netherlands.

Abstract

[This corrects the article DOI: 10.1016/j.lanepe.2021.100142.].